...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
【24h】

Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma

机译:将下一代测序纳入常规临床护理以直接治疗头颈部鳞状细胞癌

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: The clinical impact of next-generation sequencing (NGS) in patients with head and neck squamous cell carcinoma (HNSCC) has not been described. We aimed to evaluate the clinical impact of NGS in the routine care of patients with HNSCC and to correlate genomic alterations with clinical outcomes.
机译:目的:尚未描述下一代测序(NGS)对头颈部鳞状细胞癌(HNSCC)患者的临床影响。我们旨在评估NGS在HNSCC患者常规护理中的临床影响,并将基因组改变与临床结果相关联。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号